Consent documents, reproductive issues, and the inclusion of women in clinical trials

Academic Medicine

Volumn 74, Issue 3, 1999, Pages 275-281

  Nolan, Marie T ^a   Pressman, Eva K ^a   Starklauf, Barbara L ^b   Gregory, R Elizabeth ^c,d  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d ALZA CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; CLINICAL STUDY; FETUS RISK; HUMAN; INFORMED CONSENT; MEDICAL RESEARCH; PATIENT INFORMATION; PREGNANCY COMPLICATION; PRIORITY JOURNAL;

EID: 0032978194     PISSN: 10402446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001888-199903000-00019     Document Type: Article

References (15)

1. Bennett JC. Inclusion of women in clinical trials: policies for population subgroups. N Engl J Med. 1993; 329: 288-91.
2. NIH Revitalization Act of 1993. U.S. Congress Public Law 103-43. [National Institute of Health Revitalization Amendment]. Washington, DC:NIH, 1993; June 10.
3. Food and Drug Administration. Guideline for the Study and Evaluation of Gender Differences in the Clinical Evaluation of Drugs, Notice. Fed Reg. Thursday, July 22, 1993; 58:39406-16.
4. Atbel SK, Olin BR (eds). Drug Facts and Comparisons, looseleaf edition. St. Louis, MO: Facts and Comparisons Wolters Kluwer, 1997.
5. Brent RL. The effects of embryonic and fetal exposure to x-ray, microwaves, and ultrasound. Clin Perinatol. 1986; 13:615.
6. Reprotox [computer software]. Washington, DC: Reproductive Toxicology Center, 1997.
7. American College of Obstetricians and Gynecologists. Teratology. (Technical Bulletin No. 236). Washington, DC: ACOG, April 1997.
8. Physician's Desk Reference. 1997 ed. Montvale, NJ: Medical Economics Data, 1997.
9. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. DHEW Pub No. (05) 78-0012; 1978.
10. Wermeling DP, Selwitz AS. Current issues surrounding women and minorities in drug trials. Ann Pharmacother. 1993; 27:904-11.
11. McCarthy CR. Historical background of clinical trials involving women and minorities. Acad Med. 1994;69: 695-8.
12. Rosenfeld JA, Everett KD. Factors related to planned and unplanned pregnancies. J Fam Pract. 1996; 43:161-6.
13. Brown SS, Eisenberg L (eds). The Best Intentions: Unintended Pregnancy and the Wellbeing of Children and Families. Washington, DC: National Academy Press, 1995.
14. Potter LS. How effective are contraceptives? The determination and measurement of pregnancy rates. Obstet Gynecol. 1996;88: 13S-23S.
15. Lai KK. Attitudes toward childbearing and changes in sexual and contraceptive practices among HIV-infected women. Cleveland Clin J Med. 1994;61:132-6.